Incannex Healthcare (IXHL) Intangibles (2022 - 2023)
Incannex Healthcare's (IXHL) quarterly Intangibles came in at $52.7 million in Q2 2023, little changed quarter-over-quarter from $52.7 million in Q4 2022.
Analysis
Incannex Healthcare (IXHL) Intangibles (2022 - 2023) Analysis & Trends
Incannex Healthcare has disclosed Intangibles across 2 years of filings, most recently posting $52.7 million for Q2 2023.
- In Q2 2023, Intangibles changed N/A year-over-year to $52.7 million; the TTM figure through Jun 2023 stood at $52.7 million (changed N/A YoY), while the FY2023 annual figure was $52.7 million, changed N/A from the prior year.
- Intangibles came in at $52.7 million for Q2 2023 at Incannex Healthcare, roughly flat from $52.7 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $52.7 million in Q4 2022 to a low of $52.7 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 47.05 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 30.64 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | 63.28 Mn |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 103.20 Mn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | - |